MoonLake Share Price

MoonLake Share Price

NASDAQ: MLTX | Small Cap | Healthcare
$11.07
+$0.02 (0.18%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

MoonLake Stock Performance

Open
$10.72
Prev. Close
$11.05
Circuit Range
N/A
Day Range
$10.72 - $11.29
Year Range
$9.47 - $23.25
Volume
94,160
Average Traded
$11.07

MoonLake Share Price Today

As of 22 November 2026, MoonLake Immunotherapeutics Class A's share price is $11.07. The stock opened at $10.72, compared to its previous close of $11.05. During today's trading session, MoonLake Immunotherapeutics Class A's share price traded between $10.72 and $11.29, with an average price of $11.01. Over the past 52 weeks, the stock has recorded a high of $23.25 and a low of $9.47. In terms of performance, MoonLake Immunotherapeutics Class A's share price has declined by 42.24% over the last six months and is down 19.45% on a year-on-year basis.

MoonLake Share Price Chart

Line chart of the MoonLake price trend over the selected period. The price rose overall, ranging from 10.72 to 11.30, ending at 11.09.
$10.72$11.29
L
Show Current Price
H

MoonLake Stock Fundamentals & Key Indicators

Market Cap
$713.94M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.19
Revenue (TTM)
$0.00
Return On Equity (TTM)
-71.03%
Profit Margin
N/A
Debt to Equity
0.26
Quarterly Earnings Growth YoY
-32.54%

MoonLake Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$60.02-$69.71-$61.81-$79.55
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-16.14%11.33%-28.70%

MoonLake Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$49.97-$36.01-$118.94-$227.32
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A27.94%-230.30%-91.12%

MoonLake Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.743.6412.370.33
Current Assets421.69474.29514.1776.51
Total Assets424.43477.93526.5476.84
Non Current Liabilities74.472.083.080.41
Current Liabilities45.4822.469.977.67
Total Liabilities119.9524.5413.058.08
Shareholders' Equity304.48453.39513.4968.77

MoonLake Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-196.01-116.59-42.78-55.89
Investing202.99-205.6-25.18-32.34
Financing146.051.31479.7119.69

About MoonLake

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

MoonLake Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$11.88
$11.04
-6.20%
Oct 2026
$11.69
$11.77
+0.34%
Sep 2026
$15.05
$11.72
-24.55%
Aug 2026
$18.37
$15.54
-15.75%
Jul 2026
$19.75
$18.45
-5.26%
Jun 2026
$18.91
$19.47
+1.54%
May 2026
$16.37
$19.18
+17.35%
Apr 2026
$17.29
$16.34
-12.29%
Mar 2026
$17.29
$18.63
+6.34%
Feb 2026
$16.35
$17.52
+11.84%
Jan 2026
$13.19
$15.66
+18.99%
Dec 2025
$13.59
$13.16
-4.25%

MoonLake Share Price FAQs